T3 Pharmaceuticals
Latest round
- Series A
Last raised
- Sep 2019
Total raised
- $12M
Investors
- 2
About T3 Pharmaceuticals
T3 Pharmaceuticals AG, founded in 2015 and headquartered in Allschwil, Switzerland, specializes in creating advanced biopharmaceutical products. The company was co-founded by Christoph Kasper, Marlise Amstutz, and Simon Ittig, with Simon Ittig currently serving as CEO.T3 Pharmaceuticals AG specializes in developing innovative biopharmaceutical products that address significant unmet medical needs in oncology and immuno-oncology. Their primary offerings include advanced therapies designed to harness the immune system's power in combatting various cancers, enhancing existing treatment protocols and providing personalized medicine solutions.T3 Pharmaceuticals AG generates revenue through strategic partnerships and collaborations in the biopharmaceutical sector. Their business model includes B2B agreements with healthcare institutions and pharmaceutical companies, enabling the distribution and administration of their proprietary therapies. Revenue streams are structured around milestone payments, licensing agreements, and potential profit-sharing from product sales. The company is focusing on the launch of new products designed to meet the evolving needs of oncology patients. Additionally, T3 Pharma plans to expand its operations into new geographic regions, targeting markets in Asia and North America by 2023.
Who invested in T3 Pharmaceuticals
2 investors across 1 round
See all investors in T3 Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 26, 2019
Amount
$12M
Investors
Questions about T3 Pharmaceuticals
Who invested in T3 Pharmaceuticals?
T3 Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has T3 Pharmaceuticals raised?
T3 Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did T3 Pharmaceuticals last raise money?
T3 Pharmaceuticals's most recent round on record is a Series A, in Sep 2019.
What does T3 Pharmaceuticals do?
T3 Pharmaceuticals AG, founded in 2015 and headquartered in Allschwil, Switzerland, specializes in creating advanced biopharmaceutical products.
Where is T3 Pharmaceuticals headquartered?
T3 Pharmaceuticals is headquartered in Allschwil, Switzerland.
Which VCs invest in companies like T3 Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at T3 Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like T3 Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.